Status:
UNKNOWN
African Covid-19 Critical Care Outcomes Study
Lead Sponsor:
University of Cape Town
Collaborating Sponsors:
University of KwaZulu
Conditions:
Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Brief Summary
The infectious disease COVID-19, caused by coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has been declared a pandemic and an international healthcare emergency by the World...
Detailed Description
The infectious disease COVID-19, caused by coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has been declared a pandemic and an international healthcare emergency by the World...
Eligibility Criteria
Inclusion
- All consecutive patients at participating centres referred for high-care unit or intensive care unit admission who have suspected or known COVID-19
Exclusion
- None
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04367207
Start Date
May 1 2020
End Date
December 31 2020
Last Update
September 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groote Schuur Hospital
Cape Town, Western Cape, South Africa, 7599